At the 2025 Robin Hood Investors Conference, Michael Buckley of Duquesne Family Office pitches one biotech equity as a best idea, highlighting its early cancer detection technology and long-term growth potential.
Also see our coverage of the 2024 Robin Hood Investors Conference, 2023 Robin Hood Investors Conference, and the 2018 Robin Hood Investors Conference.
We have full coverage - stay tuned and check this page and links for our full coverage.
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full ArticleAlready a member? Log in here
